The Institute for Life Science Entrepreneurship at Kean University is joining the CARB-X Global Accelerator Network, an international consortium of committed scientists and experts working to develop new antibiotics, vaccines, diagnostics and other products to fight drug-resistant superbugs. ILSE and CARB-X (Combating Antibiotic Resistant Bacterial Biopharmaceutical Accelerator) signed a three-year agreement under which ILSE will serve as an accelerator, providing drug discovery and diagnostics expertise, business strategy and other .support to CARB-X’s growing portfolio of innovative antibacterial development projects. Read more here.